Abstract

Although the inhibitory roles of ursolic acid (UA) have been established in various tumors, its effects on the stemness of non‐small cell lung cancer (NSCLC) cells are still unclear. Here, we constructed NSCLC cells with paclitaxel resistance (A549‐PR) and showed that A549‐PR exhibited a remarkably stronger stemness than the parental A549 cells, which is evident by the increase of spheroid formation capacity, stemness marker expression, and ALDH1 activity. Additionally, UA significantly reduced the stemness and paclitaxel resistance of A549‐PR cells. Mechanistic investigations revealed that UA inhibited the miR‐149‐5p/MyD88 signaling, which is responsible for UA‐mediated effects on the stemness of A549‐PR cells. Notably, miR‐149‐5p/MyD88 axis promoted the stemness of A549 cells, while inhibition of this axis attenuated the stemness of A549‐PR cells. Therefore, these results suggest that UA could attenuate the stemness and chemoresistance of NSCLC cells through targeting miR‐149‐5p/MyD88 axis.